GlassScriptPhysician profile
Oneil M Biscette
NPI 1891848966
$492.54
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.51 · 2020: $168 · 2021: $78.48 · 2023: $158 · 2024: $27.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $113.04 | 2023 | Lumigan |
| Regeneron Healthcare Solutions, INC. | $85.52 | 2019-2021 | |
| Tracpatch Health, INC | $72.93 | 2020 | |
| Alcon Vision LLC | $62.50 | 2021 | |
| Novartis Pharmaceuticals Corporation | $39.41 | 2019-2020 | |
| Alimera Sciences, INC. | $26.98 | 2020 | |
| Apellis Pharmaceuticals, INC. | $24.44 | 2023 | Syfovre |
| Genentech USA, INC. | $20.66 | 2023 | Vabysmo |
| Astellas Pharma US INC | $20.65 | 2024 | Izervay |
| Allergan, INC. | $19.70 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $6.71 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oneil Biscette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.